Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2003 | 1 |
2004 | 2 |
2005 | 2 |
2006 | 1 |
2007 | 1 |
2008 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Potent antileukemic interactions between flavopiridol and TRAIL/Apo2L involve flavopiridol-mediated XIAP downregulation.
Leukemia. 2004 Nov;18(11):1780-8. doi: 10.1038/sj.leu.2403491.
Leukemia. 2004.
PMID: 15385934
Mechanism and functional role of XIAP and Mcl-1 down-regulation in flavopiridol/vorinostat antileukemic interactions.
Rosato RR, Almenara JA, Kolla SS, Maggio SC, Coe S, Giménez MS, Dent P, Grant S.
Rosato RR, et al. Among authors: maggio sc.
Mol Cancer Ther. 2007 Feb;6(2):692-702. doi: 10.1158/1535-7163.MCT-06-0562.
Mol Cancer Ther. 2007.
PMID: 17308065
Item in Clipboard
Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactions.
Rosato RR, Almenara JA, Maggio SC, Coe S, Atadja P, Dent P, Grant S.
Rosato RR, et al. Among authors: maggio sc.
Mol Cancer Ther. 2008 Oct;7(10):3285-97. doi: 10.1158/1535-7163.MCT-08-0385.
Mol Cancer Ther. 2008.
PMID: 18852132
Free PMC article.
Item in Clipboard
The histone deacetylase inhibitor MS-275 interacts synergistically with fludarabine to induce apoptosis in human leukemia cells.
Maggio SC, Rosato RR, Kramer LB, Dai Y, Rahmani M, Paik DS, Czarnik AC, Payne SG, Spiegel S, Grant S.
Maggio SC, et al.
Cancer Res. 2004 Apr 1;64(7):2590-600. doi: 10.1158/0008-5472.can-03-2631.
Cancer Res. 2004.
PMID: 15059916
Item in Clipboard
Potentiation of the lethality of the histone deacetylase inhibitor LAQ824 by the cyclin-dependent kinase inhibitor roscovitine in human leukemia cells.
Rosato RR, Almenara JA, Maggio SC, Atadja P, Craig R, Vrana J, Dent P, Grant S.
Rosato RR, et al. Among authors: maggio sc.
Mol Cancer Ther. 2005 Nov;4(11):1772-85. doi: 10.1158/1535-7163.MCT-05-0157.
Mol Cancer Ther. 2005.
PMID: 16275999
Item in Clipboard
The histone deacetylase inhibitor LAQ824 induces human leukemia cell death through a process involving XIAP down-regulation, oxidative injury, and the acid sphingomyelinase-dependent generation of ceramide.
Rosato RR, Maggio SC, Almenara JA, Payne SG, Atadja P, Spiegel S, Dent P, Grant S.
Rosato RR, et al. Among authors: maggio sc.
Mol Pharmacol. 2006 Jan;69(1):216-25. doi: 10.1124/mol.105.017145. Epub 2005 Sep 27.
Mol Pharmacol. 2006.
PMID: 16189296
Retracted.
Item in Clipboard
Protein kinase C-dependent activation of the tumor necrosis factor receptor-mediated extrinsic cell death pathway underlies enhanced apoptosis in human myeloid leukemia cells exposed to bryostatin 1 and flavopiridol.
Cartee L, Maggio SC, Smith R, Sankala HM, Dent P, Grant S.
Cartee L, et al. Among authors: maggio sc.
Mol Cancer Ther. 2003 Jan;2(1):83-93.
Mol Cancer Ther. 2003.
PMID: 12533676
Item in Clipboard
Cite
Cite